Portal de Periódicos da CAPES

MUT-TP53: a versatile matrix for TP53 mutation verification and publication

2006; Wiley; Volume: 27; Issue: 11 Linguagem: Inglês

10.1002/humu.20395

1098-1004

Thierry Soussi, Jean Michel Rubio-Nevado, Chikashi Ishioka,

Epigenetics and DNA Methylation

Human MutationVolume 27, Issue 11 p. 1151-1154 Letter to the Editor MUT-TP53: a versatile matrix for TP53 mutation verification and publication† Thierry Soussi, Corresponding Author Thierry Soussi [email protected] Université Pierre et Marie Curie-Paris6, Department of Life Sciences, Paris, France Cancer Centrum Karolinska, Department of Oncology-Pathology, Karolinska Institut, Stockholm, SwedenUniversité P.M. Curie-Paris6, Paris, F-75005 FranceSearch for more papers by this authorJean Michel Rubio-Nevado, Jean Michel Rubio-Nevado Université Pierre et Marie Curie-Paris6, Department of Life Sciences, Paris, FranceSearch for more papers by this authorChikashi Ishioka, Chikashi Ishioka Department of Clinical Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, JapanSearch for more papers by this author Thierry Soussi, Corresponding Author Thierry Soussi [email protected] Université Pierre et Marie Curie-Paris6, Department of Life Sciences, Paris, France Cancer Centrum Karolinska, Department of Oncology-Pathology, Karolinska Institut, Stockholm, SwedenUniversité P.M. Curie-Paris6, Paris, F-75005 FranceSearch for more papers by this authorJean Michel Rubio-Nevado, Jean Michel Rubio-Nevado Université Pierre et Marie Curie-Paris6, Department of Life Sciences, Paris, FranceSearch for more papers by this authorChikashi Ishioka, Chikashi Ishioka Department of Clinical Oncology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, JapanSearch for more papers by this author First published: 29 August 2006 https://doi.org/10.1002/humu.20395Citations: 6 † Communicated by Richard G.S. Cotton AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Bitton A, Neuman MD, Barnoya J, Glantz SA. 2005. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest. Lancet 365: 531– 540. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15: 7– 12. Gao HG, Chen JK, Stewart J, Song B, Rayappa C, Whong WZ, Ong T. 1997. Distribution of p53 and K-ras mutations in human lung cancer tissues. Carcinogenesis 18: 473– 478. Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C, Soussi T. 2006. The UMD TP53 database and website: update and revisions. Hum Mutat 27: 14– 20. Horaitis O, Cotton RG. 2004. The challenge of documenting mutation across the genome: the human genome variation society approach. Hum Mutat 23: 447– 452. Kato S, Han SY, Liu W, Otsuka K, Shibata H, Kanamaru R, Ishioka C. 2003. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci USA 100: 8424– 8429. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P. 2002. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607– 614. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. 2004. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ 157: 247– 270. Soussi T, Béroud C. 2001. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1: 233– 240. Soussi T, Béroud C. 2003. Significance of TP53 mutations in human cancer: A critical analysis of mutations at CpG dinucleotides. Hum Mutat 21: 192– 200. Soussi T, Kato S, Levy PP, Ishioka C. 2005. Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations. Hum Mutat 25: 6– 17. Soussi T, Asselain B, Hamroun D, Kato S, Ishioka C, Claustres M, Beroud C. 2006. Meta-analysis of the p53 mutation database for mutant p53 biological activity reveals a methodologic bias in mutation detection. Clin Cancer Res 12: 62– 69. Citing Literature Volume27, Issue11November 2006Pages 1151-1154 ReferencesRelatedInformation